Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HC.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.93 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.31.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.312NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.142NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.523NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.389NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.363NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.405NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.282NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.228NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
B.1.1.174NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
AY.88 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.106 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.346NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.93NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ED.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used